✨ Health and Medicines Notices
17 JUNE
NEW ZEALAND GAZETTE
1605
-
work towards improving the quality of health and disability sector information and ensuring that the most effective use is made of information
-
endeavour to address, in a consistent way throughout New Zealand, health need, and relative benefits and cost effectiveness of services
-
improve its capability to better deliver on Government’s health goals and aspirations
-
establish a reputation for openness, consistency, reliability and certainty in all its relationships with the health and disability sector and the public generally
-
carry out all contract and funding processes in a timely, effective and cost-efficient manner
-
identify, assess, manage and monitor financial and non-financial risk
-
where appropriate, inform the Ministry and the Government of the risks identified in innovative strategies so consideration can be given as to how such risks may be absorbed or addressed, either by the HFA itself or by Government as a whole
-
continually work to lower to the minimum reasonable level the HFA’s administration and consultancy costs and the compliance costs for those who deal with the HFA.
Dated at Wellington this 2nd day of June 1999.
WYATT CREECH, Minister of Health.
goa268
Medicines Act 1981
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Ranitidine hydrochloride 167.5 mg equivalent to 150 mg ranitidine base; Ranitidine hydrochloride 335 mg equivalent to 300 mg ranitidine base | Tablets, film coated | Salutas Pharma GmbH, Barleben, Germany | Ranihexal |
Dated this 14th day of June 1999.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
goa4372
Corrigendum
Consent to the Distribution of a Changed Medicine
In the notice published in the New Zealand Gazette, 10 June 1999, Issue No. 67, page 1546, notice No. 4118, amend the entry for Flixotide to show the name and strength in line 14 to Fluticasone propionate 50 µg/dose.
Dated this 14th day of June 1999.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
goa4370
Corrigendum
Consent to the Distribution of a New Medicine
In the notice published in the New Zealand Gazette, 10 June 1999, Issue No. 67, page 1545, notice No. 4117, amend the entries for Perfecly Clear Midstream Pregnancy Test and Perfectly Clear Pregnancy Test Strip in lines 22 and 27 to insert the word albumin after Bovine serum.
Dated this 14th day of June 1999.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
goa4371
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1999, No 71
NZLII —
NZ Gazette 1999, No 71
✨ LLM interpretation of page content
🏥
Notice to the Health Funding Authority of the Crown’s Objectives for Health and Disability Services for 1999/2000
(continued from previous page)
🏥 Health & Social Welfare2 June 1999
Health Funding Authority, Crown Objectives, Health Policies, Disability Services, Mental Health, Child Health, Immunisation, Disability Support, Population Health, Public Health, Breast Cancer Screening, Hepatitis B, Service Coordination, Intersectoral Collaboration, Health Sector Capability, Sustainability
- WYATT CREECH, Minister of Health
🏥 Consent to the Distribution of a New Medicine
🏥 Health & Social Welfare14 June 1999
Medicines Act, New Medicine, Ranitidine hydrochloride, Ranihexal, Salutas Pharma GmbH
- G. R. BOYD, Chief Advisor, Regulation and Safety
🏥 Corrigendum: Consent to the Distribution of a Changed Medicine
🏥 Health & Social Welfare14 June 1999
Corrigendum, Medicines Act, Changed Medicine, Flixotide, Fluticasone propionate
- G. R. BOYD, Chief Advisor, Regulation and Safety
🏥 Corrigendum: Consent to the Distribution of a New Medicine
🏥 Health & Social Welfare14 June 1999
Corrigendum, Medicines Act, New Medicine, Perfectly Clear Midstream Pregnancy Test, Perfectly Clear Pregnancy Test Strip
- G. R. BOYD, Chief Advisor, Regulation and Safety